Individual results may vary, and some practices may be unsuitable or unsafe for certain individuals
ADJUST-T1D, an investigator-initiated double-blind randomized phase 2 study, assessed the efficacy of once-weekly semaglutide as add-on therapy in individuals aged 1865 years who had been living with type 1 diabetes for more than a year, had inadequate glycemic management (A1C 7%10%) despite AID therapy for more than three months, and a body mass index (BMI) 30 kg/m 2
Moreover, alcoholic beverages often lack nutritional value and can lead to poor dietary choices, further complicating efforts to manage diabetes and maintain a healthy weight
95% CI, 0.78-0.97) and renal vascular resistance (ETR = 0.96
Ozempic, like other GLP-1 medications, is available only by prescription
The reactions are generally mild and resolve within 24-48 hours